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The 5-toxin is a 26-residue peptide from Staphylococcus
aureus with the sequence formyl-MAQDIISTIGDLVKWII-
DTVNKFTKK. NMR studies indicate that the segment
nSTIGDLVKWIIDTV occurs in an a-helical conformation
in the toxin. A synthetic peptide corresponding to this
segment, although helical, did not exhibit hemolytic activity.
Since charged residues like D and K are likely to modulate
cytolytic activity, analogs of the 16-residue peptide were
synthesized where D was systematically replaced by K.
Analogs in which the first D and both Ds were replaced
by K showed potent antimicrobial and hemolytic activities.
The analog in which the second D was replaced by K was
relatively less active. However, all the peptides showed
an a-helical structure with similar helical content The
activities of the peptides were found to correlate directly
with their ability to penneabilize model membranes. Thus,
by minimal judicious replacement of charged amlno acids,
it should be possible to generate cytolytic peptides from
short segments of peptide toxins.
Key words: antimicrobial activity/helical segment/8-hemolysin/
hemolytic activity/16-residue peptides
Introduction
Peptides form a part of the host defense mechanism in insects
(Boman, 1991; Hoffman and Hetru, 1992; Hultmark, 1993),
amphibians (Bevins and Zasloff, 1990) and mammals, includ-
ing humans (Lehrer et al, 1991). While peptides 5-toxin
(Fitton et al, 1980) and bombolitin (Argiolas and Pisano,
1985) are hemolytic, others like cecropins (Boman, 1991) and
magainins (Bevins and Zasloff, 1990) exhibit only antimicro-
bial activities. Melittin exhibits potent hemolytic (Habermann
and Jentisch, 1967) and antibacterial activities (Boman et al,
1989). There has been considerable interest in recent years on
the structure, function and biology of antimicrobial peptides
due to the serious problem of resistance to conventional
antibiotics that are used therapeutically (Neu, 1992; Silver and
Bostian, 1993). Considering the fact that peptides are used by
organisms across the evolutionary scale to combat bacteria
and also the observation that these peptides exert their activity
by permeabilizing the bacterial plasma membrane (Christensen
et al, 1988; Duclhier et al, 1989; Lehrer et al, 1989; Ohta
et al, 1992), it is conceivable that resistance may not be
developed easily by them. Although cecropins, magainins and
defensins exhibit potent, broad-spectrum antimicrobial activity
(Saberwal and Nagaraj, 1994), they may be of limited use in
therapies because they are composed of 25-40 residues which
would be expensive to synthesize. Hence, it would be pertinent
to explore the possibility of generating shorter peptides (-15
residues) with antimicrobial activity, especially ones which are
parts of longer toxins. Structure-function correlations with
shorter segments of peptide toxins would also help in determin-
ing the minima] structural requirements for biological activity.
In this paper we describe the antimicrobial and hemolytic
activities of peptides derived from a 16-residue peptide corres-
ponding to the helical region of the hemolytic toxin 5-
hemolysin.
Materials and methods
Synthesis of peptides
Peptides nSTIGDLVKWIIDTV (1), IISTIGKLVKWIIDTV
(2), IISTIGDLVKWnKTV (3) and IISTIGKLVKWIIKTV (4),
were synthesized by solid-phase methods using fluorenylme-
thoxycarbonyl (Fmoc) chemistry protocols (Atherton and Shep-
pard, 1989). The bold amino acids indicate changes from 5-
toxin. Peptides 1 and 2 were synthesized manually using p-
hydroxymethyl phenoxymethyl polystyrene resin (HMP resin;
Applied Biosystems, Foster City, CA). Peptides 3 and 4
were synthesized using KA resin (Nova Biochem, UK) on a
Pharmacia LKB Biolynx 4175 peptide synthesizer. Peptide
chains were assembled using Fmoc amino acid and 1-hydroxy
benzotriazole (HOBT) active esters. Fmoc aihino acids were
obtained from Nova Biochem (UK). Peptides were deprotected
from resin after synthesis by acidolytic cleavage using trifluo-
roacetic acid (TFA), thioanisole, meta-cresol and ethanedithiol
(10:1:1:0.5). Purification of peptides was achieved by fast
performance liquid chromatography (FPLC) using solvents A
(0.1% TFA in water) and B (0.1% TFA in CH3CN) on Pep
RPC HR (5/5) reverse-phase (C18) columns purchased from
Pharmacia. The purified peptides were characterized by amino
acid analysis on a Pharmacia LKB 4151 Alpha Plus amino
acid analyzer and sequencing on an Applied Biosystems 473A
automated protein sequencer. The data were fully compatible
with the expected structures.
CD studies
CD spectra were recorded in 5 mM HEPES buffer at pH 7.4
containing 10 mM SDS on a Jobin Yvon Dichrograph V
spectropolarimeter at 25°C using a quartz cell of 1 mm path
length. Data are represented as mean residue ellipticities.
Permeabilization of lipid vesicles
The ability of peptides to cause release of carboxyfluorescein
(CF) was checked by monitoring the fluorescence intensity
of CF encapsulated in dioleoyl phosphatidylcholine (DOPC)
vesicles at self-quench concentrations. Lipid film was dispersed
in 5 mM HEPES, pH 7.4, 75 mM NaCl and 50 mM CF, and
was sonicated in a Branson sonifier. Liposomes were separated
from non-encapsulated CF by gel filtration on a Sephadex G-
75 column (elution buffer: 5 mM HEPES, pH 7.4, 125 mM
NaCl and 1 mM EDTA). The excitation monochromator was
set at 493 nm and the emission at 520 nm was continuously
monitored after the addition of peptide from a stock solution
to the lipid vesicles. The fluorescence of CF is enhanced
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considerably on dilution; hence the increase in fluorescence is
a measure of vesicle permeabilization. Complete release of
CF was obtained by the addition of Triton X-100 (1% v/v).
All experiments were carried out at 25°C in a Hitachi 650-
10S spectrofluorimeter.
Hemolytic activity
It has been observed that natural 5-toxin causes the lysis of
guinea pig erythrocytes to a slightly greater extent than
erythrocytes from other mammalian species (Alouf et al,
1989). Hence, we have examined the ability of peptides 1-4
to cause lysis of guinea pig erythrocytes. Freshly collected
blood from a guinea pig was centrifuged and washed with 5
mM HEPES buffer (pH 7.4) containing 150 mM NaCl to
remove the buffy coat. Erythrocytes (0.4% v/v) were incubated
at 37°C in the same buffer with different concentrations of
peptide in duplicate. Time course measurements indicated that
lysis was complete in 20 min. Lysis at the end of incubation
for 30 min was measured for all the peptides. Samples were
centrifuged and the A540 of the supernatant was measured. The
absorbance obtained by the treatment of erythrocytes with 1 %
Triton X-100 was taken as 100%.
Antimicrobial activity
The antimicrobial activities were assayed by adding different
concentrations of peptides to 1 ml of synthetic medium (Miller,
1972) containing -106 c.f.uVml of the test organisms which
were Escherichia coli W160-37, and Staphylococcus aureus
in duplicate. Microbial growth was determined by increase in
O D ^ , after incubation at 37°C for 6-9 h depending upon
growth rate. The lowest concentration of peptide that com-
pletely inhibited growth was recorded as the minimal inhibitory
concentration (MIC).
Results
The structure of 8-toxin has been determined in methanol and
micelles by 'H NMR. Based upon observed nuclear Overhauser
enhancements (NOE) and restrained molecular dynamics
analysis, Tappin et al. (1988) have suggested that residues 2 -
20 form a stable helix in methanol at pH 3.0. Lee et al. (1987)
have argued, based on their NMR data, that residues 5-23 are
in a helical conformation in micelles. An examination of the
NMR data of Tappin et al. (1988) indicated that J N H - ^ H is
uniformly low between residues 6 and 20. Also, the conforma-
tion of 5-toxin in micelles would be more relevant to membrane
interactions. Hence, we chose the segment IISTIGDLVKWII-
DTV to assess its biological activity as well as for 'engineer-
ing'. The sequence IISTIGDLVKWIIDTV has one lysine and
two aspartic acid residues. Since positively charged amino
acids like lysine play an important role in determining the
activity of antibacterial and hemolytic peptides like cecropins,
magainins and melittin (Bernheimer and Rudy, 1986; Saberwal
and Nagaraj, 1994), variants of this 16-residue peptide, where
D(7) and D(14) were replaced by lysines, i.e. peptides 2-4
(sequences indicated in Materials and methods), were syn-
thesized.
Conformation of peptides
Since the ability to adopt helical conformation is an important
requirement for binding to membranes and permeabilizing
them in the case of membrane-interacting peptides (Kaiser and
Kezdy, 1987), the conformation of peptides 1-4 was examined
by CD spectroscopy particularly in the hydrophobic environ-
ment. The CD spectra of the peptides are shown in Figure
260
Fig. 1. CD spectra of peptides in micelles of SDS: peptide 1 (—), peptide 2
( ), peptide 3 ( - • - ) and peptide 4 (• • •). Peptide concentration =
10 nmol.
CONCOmuTtOH (aM) co N c E rmunoit
Fig. 2. Hemolytic and antimicrobial activity of peptides. (A) Hemolytic
activity of peptides 2 ( • ) , 3 ( • ) and 4 (O). Data points correspond to the
mean of two independent observations. The variation was 30% in the low
concentration range, i.e. up to 10 |iM for peptides 2 and 4, and up to 20
(iM for peptide 3. Above these concentrations the variation was 15%. (B)
Antimicrobial activity against E.coli: peptides 2 ( • ) , 3 ( • ) and 4 (O). Data
points correspond to the mean of two independent observations. The
variation was -5%.
1. The spectra are characteristic of peptides in a helical
conformation. An estimation of the secondary structural para-
meters using the program LINCOMB (Perczel et al, 1992)
with the template CD curves for polylysine (Yang et al, 1986)
yielded helix and random conformation with no P-sheet. The
helical content for the four peptides was between 65 and 75%.
The spectrum of peptide 1 indicates that the segment which
is helical in the entire toxin has the tendency to be helical
even in isolation. The spectra of peptides 2-4 indicate that the
replacement of Asp by Lys does not affect structure.
Hemolytic activity
The hemolytic activity of peptides 1—4 was determined against
guinea pig erythrocytes. Peptide 1, corresponding to the helical
region of 5-toxin, did not exhibit hemolytic activity even at a
concentration of 100 u,M. However, peptides 2-4 have the
ability to lyse erythrocytes, as shown in Figure 2A. Peptides
2 and 4 cause 50% lysis at concentrations of -15 and 11 ^M,
whereas peptide 3 is relatively inactive, with 50% lysis
occurring at -40 (iM.
Antimicrobial activity
The antimicrobial activity of the peptides against E.coli and
S.aureus was examined. Peptide 1 did not exhibit antimicrobial
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Fig. 3. Release of CF from small unilamellar vesicles of
dioleoylphosphatidylcholine by peptides I (A), 2 (B), 3 (C) and 4 (D).
Ratios indicated in the figure are peptide:lipid molar ratios. Lipid = 200
jiM.
activity even at concentrations >100 (J.g/ml. Peptides 2—4
exhibited activity against both micro-organisms. The growth
inhibition of E.coli in the presence of peptides 2-4 is shown
in Figure 2B. The most potent peptide is peptide 4, with a
MIC of 3 ^M. Peptide 2 has a MIC of 8 |iM, while peptide
3 is less active with a MIC of -35 |xM. The MIC against
S.aureus was 16-22 |iM for peptide 2 and 3^4 (iM for peptide
4. No inhibition of growth was observed for peptide 3, even
at a concentration of -75 (J.M. The extents of hemolysis at
MIC for peptides 2, 3 and 4 were 5, 50 and - 3 % , respectively.
The values indicate percentage lysis as compared with that
obtained by Triton X-100. At MIC against E.coli, peptides 2
and 4 exhibit very little hemolytic activity. Thus, by changing
the location of charged amino acids in helical peptides (like
1^4), peptides with varying antimicrobial and hemolytic activit-
ies can be generated.
Membrane-permeabilizing properties
Antimicrobial and hemolytic peptides, as well as several
peptide toxins which form channels in membranes under the
influence of a potential (Sansom, 1991), also permeabilize
lipid vesicles which results in the efflux of trapped solutes
like CF and calcein (Kayalar and Duzgunes, 1986; Menestrina,
1988; Schwarz and Robert, 1990; Shai et al., 1990; Vaz Gomes
el al, 1993; Saberwal and Nagaraj, 1994). The extent of
permeabilization was found to correlate with antimicrobial
and/or hemolytic activities. Since the extents of antimicrobial
and hemolytic activities of peptides \-A are different, with
peptide 1 being inactive, the membrane-permeabilizing abilities
of the peptides were examined in model membranes and the
data are presented in Figure 3. Peptide 1 is not effective in
permeabilizing lipid vesicles as only at a peptide:lipid ratio of
1:10 is 60% release observed at 100 s. At peptide:lipid ratios
of 1:13 and 1:10 complete release of CF was observed after
20 min. Peptides 2-4 permeabilize lipid vesicles effectively.
The results indicate that peptide 4 permeabilizes lipid vesicles
most effectively, followed by peptide 2. No decrease in 90°
scatter of lipid vesicles was observed at lipid:peptide ratios
where maximal CF release occurred, indicating that the lysis
of lipid vesicles did not occur. The model membrane-per-
meabilizing abilities of peptides 1-4 clearly correlate well
with their antimicrobial and hemolytic activities, indicating
Generation of analogs with potent antimicrobial and hemolytic activities
that their association with lipid components of membranes and
their ability to permeabilize them is an important determinant
of cytolytic activity.
Discussion
The 5-toxin is a 26-residue peptide isolated from S.aureus
with hemolytic activity against a variety of red blood cells
(RBCs; Yianni et al., 1986). Unlike melittin, the peptide does
not inhibit bacterial growth (Dhople and Nagaraj, 1993). This
specificity has been proposed to arise due to differences in its
interaction with the bacterial cell surfaces and RBC surface
(Dhople and Nagaraj, 1993). Structural analysis of the toxin
by 'H NMR indicates a helical stretch between residues 2 and
22 with a 'frayed' C-terminal region (Tappin et al, 1988).
The stretch between residues 5 and 20 gives NOE effects
characteristic of an ordered helical conformation and slow
exchange rates for amide hydrogens (Tappin et al., 1988). This
region is thus likely to be important for the structure and
function of the toxin. Hence, we chose this stretch to evaluate
its importance in determining the biological activity of the
toxin. We also wished to examine how charged residues like
aspartic acid and lysine would modulate cytolytic activity.
Thus, analogs where Asp residues were systematically replaced
by lysine were also synthesized and their antimicrobial and
hemolytic activities examined.
Our studies indicate that the peptide nSTIGDLVKWTTDTV,
corresponding to the a-helical region of 5-toxin, can adopt
helical conformation in isolation. However, the peptide does
not possess hemolytic or antimicrobial activity. One reason
for this lack of activity could be the net charge the peptide
would have at neutral pH. The two D and K residues would
impart a net charge of — 1 at neutral pH. A net negative charge
would not favor association with either erythrocytes or bacteria
as both cells have negatively charged molecules on their
surface (Lughtenberg and Van Alphen, 1983; Viitala and
Jamefelt, 1985). Replacement of either of the D residues with
K results in peptides which would have a net positive charge
at neutral pH. Both such peptides, i.e. peptides 2 and 3, exhibit
antimicrobial and hemolytic activities. However, peptide 2
(where the first D has been replaced by a K) is more active
than peptide 3 (where the second D has been replaced by a
K), although both peptides have similar helical contents.
Peptide 2 is less active against S.aureus and peptide 3 did not
inhibit the growth of S.aureus at concentrations where the
growth of E.coli was inhibited completely. However, in the
case of peptide 4, the MICs against E.coli and S.aureus are
almost identical. It is conceivable that proteases are secreted
by S.aureus and peptides 2 and 3 are more susceptible to the
action of these proteases as compared with peptide 4. In
peptide 3, D is at the /' and K is at the i + 3 position.
Extensive analyses of protein structures (Presta and Rose,
1988; Richardson and Richardson, 1988) and studies on model
peptides (Marqusee and Baldwin, 1987) indicate that such an
arrangement would favor side-chain interactions like salt-
bridge formation. It is thus conceivable that in peptide 3 there
is salt-bridge formation between the side chains of D at the i
and K at the / + 3 positions, leaving only the side chain of K
at position 14 for interaction with erythrocyte and bacterial
cell surfaces. However, in peptide 2, where salt-bridge forma-
tion would not be favored, the side chain of the lysines would
be available for interaction. Hence, peptide 2 is more active
than peptide 3. Peptide 4, where both D residues have been
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replaced by K, is clearly more active than peptides 2 and 3.
In this peptide, at MIC hemolysis is only -5%, indicating that
increased positive charges favor antimicrobial activity.
The biological activities of the peptides correlate well with
their model membrane-permeabilizing ability. Peptides as well
as protein toxins that form channels under the influence of a
membrane potential also permeabilize small unilamellar ves-
icles like the ones used in this study, to cause efflux of
entrapped solutes (Kayalar and Duzgunes, 1986; Menestrina,
1988; Schwarz and Robert, 1990; Shai etai, 1990; Vaz Gomes
et al, 1993). Analysis of the efflux rates suggests that these
peptides permeabilize lipid vesicles by forming channels
(Schwarz and Robert, 1990; Shai et al, 1990; Vaz Gomes
et al, 1993). Since peptides \-A do not appear to lyse the
lipid vesicles, it is likely that they permeabilize lipid vesicles
by forming channels. Although peptide 1 does permeabilize
lipid vesicles, albeit inefficiently, it does not cause the lysis
of RBCs. In almost all cases, the lysis of RBCs by membrane-
active peptides proceeds through a colloid osmotic lysis
mechanism, and it is likely that in the case of peptide 1 lysis
does not occur because the volume-regulating ability of the
Na+ pump is not overcome (Bashford et al., 1986). Model
membrane permeabilization studies suggest that the motif
DXXKXXXD observed in peptide 1 does not favor channel
formation in lipid vesicles. Peptides 1-4 have an average
hydrophobicity (< / /> ) of -0.45 and hydrophobic moment
(< | i>) of -0.63. This indicates that they would associate with
membranes as they fall in the surface-active region of the
hydrophobic moment plot (Eisenberg, 1984). It is likely that
all four peptides, although exhibiting varying channel-forming
abilities, do bind to membranes. Hence, <H> and < | i>
values, although a useful index to judge the ability of a peptide
to associate with membranes, may not indicate its channel-
forming and consequently membrane-permeabilizing ability.
Studies directed towards structure-function correlations in
antibacterial and hemolytic peptides have involved the replace-
ment of amino acids and the generation of deletion peptides
(Habermann and Kowallek, 1970; Merrifield et al., 1982; Chen
et al., 1988; Zasloff et al, 1988; Boman et al, 1989). While
peptides where amino acid replacements were carried out did
result in improved antimicrobial activity, the deletion peptides
were often inactive, suggesting a minimal length requirement
for activity. Peptides corresponding to the helical segment of 5-
toxin, IISTIGDLVKWIIDTV, do not appear to have hemolytic
activities exhibited by the parent toxin. However, by judicious
replacement of D by K in the above sequence, we have been
able to generate peptides with antimicrobial and hemolytic
activities. By adopting a similar approach, it should be possible
to derive short peptides of -15-16 residues with potency
essentially comparable with or even greater than the parent
peptides. Such an approach would be necessary for cecropins
and defensins because although they are potent antibacterial
agents (Bevins and Zasloff, 1990; Lehrer et al, 1991), they
are composed of -36 residues and would be of limited use as
therapeutic agents. Short peptides would be more appropriate
for therapeutic consideration. Our approach reported here, as
well as that of Andreu et al (1992) which involves cecropin
A-melittin hybrids, indicate that it should be possible to
develop ~15-16-residue peptides with considerable potency.
Our approach would also help in determining the requirements
for the antibacterial and hemolytic activities of the parent
peptides and should help in developing analogs with increased
potency as compared with the parent peptides.
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